118 related articles for article (PubMed ID: 18272443)
1. [Hemodialysis procedure in a patient treated with radioactive iodine].
Brunet P; Bourrelly M; Mundler O; Bouvier C; Faure V; Opris A; Bouchouareb D; Indreies M; Ramananarivo P; Dussol B; Berland Y
Nephrol Ther; 2008 Jun; 4(3):196-201. PubMed ID: 18272443
[TBL] [Abstract][Full Text] [Related]
2. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
Modarresifar H; Almodovar S; Bass WB; Ojha B
Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
[TBL] [Abstract][Full Text] [Related]
3. Radiation protection procedures in 131I treatments for thyroid cancer in patients requiring hemodialysis.
Fioroni F; Sghedoni R; Grassi E; Piccagli V; Sollini M; Filice A; Versari A; Iori M
Nucl Med Commun; 2014 Jun; 35(6):626-30. PubMed ID: 24584218
[TBL] [Abstract][Full Text] [Related]
4. Liquid discharges from patients undergoing 131I treatments.
Barquero R; Basurto F; Nuñez C; Esteban R
J Environ Radioact; 2008 Oct; 99(10):1530-4. PubMed ID: 18243440
[TBL] [Abstract][Full Text] [Related]
5. Radioactive 131I use in end-stage renal disease: nightmare or nuisance?
Sinsakul M; Ali A
Semin Dial; 2004; 17(1):53-6. PubMed ID: 14717812
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis in patients requiring 131I treatment for thyroid carcinoma.
Fofi C; Festuccia F; Barberi S; Apponi F; Chiacchiararelli L; Scopinaro F; Punzo G; Menè P
Int J Artif Organs; 2013 Jun; 36(6):439-43. PubMed ID: 23653300
[TBL] [Abstract][Full Text] [Related]
7. Radiation safety implications of 131I treatment in a patient with Grave's disease undergoing home hemodialysis.
Simpson JB; Godwin GA
Health Phys; 2006 Dec; 91(6):570-3. PubMed ID: 17099400
[TBL] [Abstract][Full Text] [Related]
8. [Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis].
Zenasni N; Elkhayat S; Taleb S; Zamd M; Medkouri G; Benghanem Gharbi M; Ramdani B; Aschawa H; Guensi A
Nephrol Ther; 2015 Apr; 11(2):114-7. PubMed ID: 25709102
[TBL] [Abstract][Full Text] [Related]
9. 131I activity in urine to the sewer system due to thyroidal treatments.
Andrés C; Barquero R; Tortosa R; Nuñez C; del Castillo A; Vega-Carrillo HR; Alonso D
Health Phys; 2011 Aug; 101 Suppl 2():S110-5. PubMed ID: 21709491
[TBL] [Abstract][Full Text] [Related]
10. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
Murcutt G; Edwards J; Boakye J; Davenport A
Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
[TBL] [Abstract][Full Text] [Related]
12. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of thyroid diseases using 131I in a special ward with a liquid waste storage plant].
Wellner U; Schicha H
Nuklearmedizin; 1993 Jun; 32(3):149-55. PubMed ID: 8327334
[TBL] [Abstract][Full Text] [Related]
14. A new proposal for monitoring patients in nuclear medicine.
Willegaignon J; Guimarães MI; Sapienza MT; Stabin MG; Malvestiti LF; Marone M; Sordi GM
Health Phys; 2006 Dec; 91(6):624-9. PubMed ID: 17099406
[TBL] [Abstract][Full Text] [Related]
15. [Renal replacement therapy by hemodialysis: an overview].
Jacobs C
Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
[TBL] [Abstract][Full Text] [Related]
16. Radiation protection issues of treating hyperthyroidism with 131 I in patients on haemodialysis.
Homer L; Smith AH
Nucl Med Commun; 2002 Mar; 23(3):261-4. PubMed ID: 11891485
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
[TBL] [Abstract][Full Text] [Related]
18. [Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures].
Sudbrock F; Boldt F; Kobe C; Hammes J; Eschner W; Schicha H
Nuklearmedizin; 2009; 48(1):17-25. PubMed ID: 19212607
[TBL] [Abstract][Full Text] [Related]
19. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
Kaczmarczyk I; Kraśniak A; Drozdz M; Chowaniec E; Gajda M; Radziszewski A; Sułowicz W
Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
[TBL] [Abstract][Full Text] [Related]
20. 131I exhalation by patients undergoing therapy of thyroid diseases.
Gründel M; Kopka B; Schulz R
Radiat Prot Dosimetry; 2008; 129(4):435-8. PubMed ID: 17993652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
